Showing results (1-10 of 320) with videos related to
Sort By:
Pageof 32
British Journal of Cancer|September 1, 1996
How should cancer presenting as a malignant pleural effusion be managed?H Bonnefoi, I E SmithBritish Journal of Cancer|February 1, 1996
Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimenH Bonnefoi, I E Smith, M E O'Brien, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2010
A review of PARP inhibitors: from bench to bedsideC Underhill, M Toulmonde, H BonnefoiRevue Medicale Suisse|March 16, 2007
[What's new in gynecology in 2006?]P Petignat, A-T Vlastos, H Bonnefoi, et al.Bulletin Du Cancer|July 8, 2010
[Biomarkers of endocrine therapy-resistance in breast cancers]P de Cremoux, M Debled, H Bonnefoi, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 26, 2006
Yolk sac tumours of the ovary: an updateP Dällenbach, H Bonnefoi, M-F Pelte, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 1, 2010
New approaches to the management of early breast cancerI E SmithOncology (Williston Park, N.Y.)|August 12, 1999
Epirubicin, cyclophosphamide, and UFT plus oral calcium folinate in advanced breast cancerI E SmithJournal of Cancer Research and Clinical Oncology|January 1, 1993
A dose-finding study of granisetron, a novel antiemetic, in patients receiving cytostatic chemotherapy. The Granisetron Study GroupI E SmithSeminars in Oncology|February 1, 1992
Carboplatin in small cell lung cancer: the Royal Marsden Hospital experienceI E SmithPageof 32